.Regeneron is actually back along with long-term follow-up for its LAG-3 prevention and also PD-1 pr...
.AstraZeneca has actually shared a very early consider the efficiency of its internal antibody-drug ...
.After declaring a phase 3 launch based on positive midstage end results, iTeos as well as GSK are e...
.The FDA needs to be actually even more available and collective to unleash a surge in approvals of ...
.It is actually an uncommonly hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and al...
.Atea Pharmaceuticals' antiviral has failed yet another COVID-19 test, but the biotech still keeps o...
.Neurocrine Biosciences' mental illness course pivot has actually stopped working. The biotech was a...
.Sanofi has created a late entrance to the radioligand gathering, spending one hundred million euros...
.After F2G's very first attempt to obtain a brand-new course of antifungal to market was actually de...
.Moderna has vowed to cut R&D costs by $1.1 billion by 2027. The selection to retract the spendin...